User:Johnjacobs998/sandbox

Patrick Rundhaug (1965-?) (Chemist, Inventor, Professor, Engineer and Author) Educated at •	Illinois Wesleyan University •	University of Arizona (Undergraduate in Chemistry, Ph.D. Program in Chemical and Environmental Engineering) •	University of Phoenix (Master's in Business Program) •	University of South Africa (Ph.D. Chemistry) •	LaCross University (Biochemistry) •	LaSalle University (Environmental Science) •	Eastern Arizona College (Business) •	Arizona Western College (Chemistry) Patrick Rundhaug is the grandson of LeRoy Rundhaug, the first person to obtain a patent for a blood transfusion apparatus after WW II. Patrick Rundhaug's areas of research interest have been electrochemical dehalogenation of halogenated hydrocarbons such as PCB's (poly-chlorinated bi-phenols), water desalination, blood chemistry, water and wastewater treatment, hazardous waste treatment, aerogel uses, and corrosion / anti-corrosion control techniques for which he obtained several U.S. patents. Some of which he legally defended for patent infringement After working at White Sands NASA Missile Test facility set up by the Lyndon B. Johnson Administration, he invented and patented (U.S. Patent 5534124)the primary method for treating and destroying PCB's currently used world-wide. This was also the focus of his Ph.D. studies at the University of Arizona in the late 1990's and 2000. He also invented and patented InstaRust® the solution used to put an instant rust finish on any metal surface. He developed a copper paint that was 50% copper by weight that can be given an instant patina and is used world wide on signs, roofs, ornamental iron, doors, rain gutters, garage doors and other trim and fencing. Early in his career he worked for Tracer Research Corporation founded by University of Arizona Professor Dr. Glenn Thompson who invented the soil gas survey technology for which he left the university in 1983 to start Tracer Research, and taking Rundhaug all over the country performing chemical research on EPA Superfund sites, government and corporate contamination interests. Later in his career he turned to more biochemistry and health related efforts and developed an arterial plaque chealatr which was manufactured for poor, underprivileged countries and communities and to be distributed through Health for Humanity, a non-profit Arizona Corporation of which Rundhaug was president. Dr. Rundhaug served as a Chief Executive Officer, President, Director, Laboratory Director, Engineer, Research Chemist, Chief Health and Safety Officer, Director of Engineering and Professor. [1] This article written by former student of Dr. Rundhaug John Jacobs, Research Chemist